Cellular Biomanufacturing Workshop

细胞生物制造工作坊

• 批准号: 2055144
• 负责人: Bhavana Singh
• 金额: $ 5.78万
• 依托单位: Children's Research Institute
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-25 至 2023-09-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2055144&HistoricalAwards=false
• 关键词: Cellular; Biomanufacturing; Workshop

This workshop was organized to promote interactions between researchers working in the nascent field of biomanufacturing, with a primary focus on therapeutic cell manufacturing. The workshop is also intended to identify significant knowledge gaps in the manufacturing of differentiated cells. This workshop will bring together the EAGER Biomanufacturing awardees from FY15 and FY16, to share results and techniques, and identify challenges and new opportunities. The two funding years cover cell differentiation and large-scale biomanufacturing. It is critical that such upstream and downstream processing research is integrated, and that all researchers in the therapeutic cell area are aware of the constraints faced in the integrated process, as well as the federal regulations surrounding biologics. The small workshop atmosphere enables high-level discussion and participation, and the participation of representatives from CBER, NIIMBL and ARMI is critical to delivering that information to the attendees.

组织这次研讨会是为了促进在生物制造这个新兴领域工作的研究人员之间的互动，主要关注治疗性细胞制造。研讨会还旨在确定分化细胞制造方面的重大知识差距。本次研讨会将汇集2015财年和2016财年热切的生物制造奖获得者，分享成果和技术，并确定挑战和新机遇。这两个资助年涵盖了细胞分化和大规模生物制造。至关重要的是，这样的上游和下游过程研究是整合的，治疗细胞领域的所有研究人员都意识到整合过程中面临的限制，以及围绕生物制品的联邦法规。小型研讨会的气氛使高级别的讨论和参与成为可能，来自CBER、NIIMBL和ARMI的代表的参与对于向与会者提供这方面的信息至关重要。